Differential Effects of Uropathogenic and Non-Uropathogenic E. coli on the Mouse Urobiome and Urine NGAL Levels.

IF 2.4 Q2 UROLOGY & NEPHROLOGY
Research and Reports in Urology Pub Date : 2026-02-25 eCollection Date: 2026-01-01 DOI:10.2147/RRU.S580953
Olivia Kathryn Lamanna, Rong Hu, Mark Khemmani, Alan J Wolfe, Suzanne L Groah, Catherine S Forster
{"title":"Differential Effects of Uropathogenic and Non-Uropathogenic <i>E. coli</i> on the Mouse Urobiome and Urine NGAL Levels.","authors":"Olivia Kathryn Lamanna, Rong Hu, Mark Khemmani, Alan J Wolfe, Suzanne L Groah, Catherine S Forster","doi":"10.2147/RRU.S580953","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To determine whether urine neutrophil gelatinase-associated lipocalin (uNGAL) or urobiome alterations can differentiate urinary tract infections (UTI) from asymptomatic bacteriuria (ASB).</p><p><strong>Methods: </strong>Female 8-week-old C57BL/6 mice were instilled with either <i>Escherichia coli</i> CFT073 (UTI model, n=12), <i>E. coli</i> 83972 (ASB model, n=12), or saline (control, n=3). uNGAL was measured daily for 3 days post-instillation. Urobiome composition was assessed pre- and post-instillation using 16S rRNA sequencing. At day 3, kidneys were harvested for culture. Comparisons were made across groups for uNGAL levels and urobiome diversity.</p><p><strong>Results: </strong>Baseline β diversity did not differ between groups. Post-instillation, β diversity significantly differed across groups (p=0.01), driven by increased relative abundance of <i>E. coli</i> in UTI mice compared to ASB mice. Median uNGAL levels increased significantly in both UTI and ASB groups relative to controls, but no significant difference was observed between UTI and ASB groups.</p><p><strong>Conclusion: </strong>Introduction of a uropathogenic <i>E. coli</i> strain reduced urobiome diversity, while a non-uropathogenic strain did not, suggesting strain-specific effects on microbial ecology. Bladder instillation itself also altered the urobiome. Elevated uNGAL levels were observed in both UTI and ASB models, indicating that while uNGAL reflects bacterial exposure, it does not distinguish between uropathogenic and non-uropathogenic <i>E. coli</i>. These findings highlight urobiome analysis as a potential tool for differentiating UTI from ASB, whereas uNGAL alone is insufficient.</p>","PeriodicalId":21008,"journal":{"name":"Research and Reports in Urology","volume":"18 ","pages":"580953"},"PeriodicalIF":2.4000,"publicationDate":"2026-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12950171/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research and Reports in Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/RRU.S580953","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To determine whether urine neutrophil gelatinase-associated lipocalin (uNGAL) or urobiome alterations can differentiate urinary tract infections (UTI) from asymptomatic bacteriuria (ASB).

Methods: Female 8-week-old C57BL/6 mice were instilled with either Escherichia coli CFT073 (UTI model, n=12), E. coli 83972 (ASB model, n=12), or saline (control, n=3). uNGAL was measured daily for 3 days post-instillation. Urobiome composition was assessed pre- and post-instillation using 16S rRNA sequencing. At day 3, kidneys were harvested for culture. Comparisons were made across groups for uNGAL levels and urobiome diversity.

Results: Baseline β diversity did not differ between groups. Post-instillation, β diversity significantly differed across groups (p=0.01), driven by increased relative abundance of E. coli in UTI mice compared to ASB mice. Median uNGAL levels increased significantly in both UTI and ASB groups relative to controls, but no significant difference was observed between UTI and ASB groups.

Conclusion: Introduction of a uropathogenic E. coli strain reduced urobiome diversity, while a non-uropathogenic strain did not, suggesting strain-specific effects on microbial ecology. Bladder instillation itself also altered the urobiome. Elevated uNGAL levels were observed in both UTI and ASB models, indicating that while uNGAL reflects bacterial exposure, it does not distinguish between uropathogenic and non-uropathogenic E. coli. These findings highlight urobiome analysis as a potential tool for differentiating UTI from ASB, whereas uNGAL alone is insufficient.

尿路致病性和非尿路致病性大肠杆菌对小鼠尿组和尿NGAL水平的差异影响。
目的:确定尿中性粒细胞明胶酶相关脂钙蛋白(uNGAL)或尿组改变是否可以区分尿路感染(UTI)和无症状细菌尿(ASB)。方法:8周龄雌性C57BL/6小鼠分别灌胃大肠杆菌CFT073 (UTI模型,n=12)、大肠杆菌83972 (ASB模型,n=12)和生理盐水(对照组,n=3)。注射后3天每天测量uNGAL。使用16S rRNA测序评估注射前后尿组组成。第3天,取肾进行培养。比较各组间uNGAL水平和尿生物多样性。结果:各组间基线β多样性无差异。注射后,各组间β多样性显著差异(p=0.01),这是由于与ASB小鼠相比,UTI小鼠中大肠杆菌的相对丰度增加所致。与对照组相比,UTI组和ASB组中位uNGAL水平均显著升高,但UTI组和ASB组之间无显著差异。结论:引入尿路致病性大肠杆菌菌株降低了尿路生物群落多样性,而引入非尿路致病性大肠杆菌菌株则没有,提示菌株对微生物生态有特异性作用。膀胱灌注本身也改变了尿组。在UTI和ASB模型中均观察到uNGAL水平升高,这表明虽然uNGAL反映了细菌暴露,但它不能区分尿路致病性和非尿路致病性大肠杆菌。这些发现强调了尿组分析作为区分尿路感染和ASB的潜在工具,而单独使用uNGAL是不够的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Research and Reports in Urology
Research and Reports in Urology UROLOGY & NEPHROLOGY-
CiteScore
3.40
自引率
0.00%
发文量
60
审稿时长
16 weeks
期刊介绍: Research and Reports in Urology is an international, peer-reviewed, open access, online journal. Publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease Investigation and treatment of urological disease Pharmacology of drugs used for the treatment of urological disease Although the main focus of the journal is to publish research and clinical results in humans; preclinical, animal and in vitro studies will be published where they will shed light on disease processes and potential new therapies. Issues of patient safety and quality of care will also be considered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书